Home/Filings/4/0000950170-24-009612
4//SEC Filing

Drape Eric 4

Accession 0000950170-24-009612

CIK 0000818686other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 7:22 AM ET

Size

5.8 KB

Accession

0000950170-24-009612

Insider Transaction Report

Form 4
Period: 2024-01-30
Drape Eric
Executive VP Global Operations
Transactions
  • Award

    Restricted Share Units

    2024-01-30+55,22655,226 total
    Ordinary Shares (55,226 underlying)
Footnotes (3)
  • [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F2]Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 5, 2024.
  • [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Documents

1 file

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001790905

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 7:22 AM ET
Size
5.8 KB